The burden of innovation in the pediatric heart center

Andrea Torzone1, Alexandra Birely

  • 1Children's Medical Center Dallas, Dallas, Texas, USA.

PubMed

Insights

Pediatric cardiac care innovation increases survival but also the number of chronically critically ill children. This growing population strains resources and burdens multidisciplinary teams, necessitating optimized care strategies.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Healthcare Systems Innovation

Background:

  • Advancements in pediatric cardiac care have led to improved survival rates for children with heart disease.
  • This success has resulted in a growing population of chronically critically ill pediatric patients.
  • These patients often have complex conditions, high resource utilization, and uncertain prognoses.

Purpose of the Study:

  • To elucidate the increasing complexity of pediatric cardiac care in the era of innovation.
  • To highlight the phenomenon of chronic critical illness within pediatric heart centers.
  • To outline the burdens on healthcare teams caring for these challenging patients and suggest alleviation strategies.

Main Methods:

  • This is a review article.
  • It synthesizes current literature and clinical observations regarding pediatric cardiac critical care.
  • It focuses on the impact of innovative therapies on patient populations and care delivery.

Main Results:

  • Improved survival in pediatric heart disease leads to a larger cohort of chronically critically ill children.
  • These patients, including preterm infants, single ventricle defects, and complex heart failure cases, require intensive interventions and prolonged care.
  • Care delivery systems face challenges in resource allocation and managing the significant emotional and cognitive burdens on multidisciplinary teams.

Conclusions:

  • The increasing number of chronically critically ill pediatric cardiac patients presents significant challenges at both systemic and team levels.
  • Innovative therapies, while improving survival, create substantial burdens that must be acknowledged and addressed.
  • Heart centers must proactively optimize care for these prolonged illnesses and support the well-being of their care teams.
Abstract

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
3.8K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
557
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
593
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
670